Bronchiectasis

The US Bronchiectasis and NTM Research Registry is a centralized database for the study of adult patients with non-cystic fibrosis bronchiectasis. In this interview Dr. Mark Metersky (UConn Health, Farmington, CT, USA) discusses the current challenges in the diagnosis and management of bronchiectasis and NTM, the aims of the registry and how it could impact […]

The phase 2 WILLOW trial (NCT03218917) investigated the efficacy, safety, tolerability, and PK of brensocatib in patients with non-cystic fibrosis bronchiectasis. We were delighted to speak with Dr Mark Metersky (UConn Health, Farmington, CT, USA) to learn more around his subgroup analysis looking at brensocatib efficacy by disease severity. The abstract ‘Outcomes of Patients With […]

touchRESPIRATORY caught up with World Bronchiectasis & NTM Conference organising committee member, Prof. Stefano Aliberti (Humanitas University, Milan and IRCCS Humanitas Research Hospital, Lombardia, Italy) to learn more around the upcoming conference taking place in Milan in 2023 and about Prof. Aliberti’s bid to become the European Respiratory Society Vice President. The 5th World Bronchiectasis […]

It was a pleasure to talk with World Bronchiectasis & NTM Conference organising committee member, Prof. Stefano Aliberti (Humanitas University, Milan and IRCCS Humanitas Research Hospital, Lombardia, Italy) to discuss the experience of meeting in person at this year’s conference, the key take home messages of the roundtable on approaches to bronchiectasis and the importance […]

touchRESPIRATORY were delighted to catch up with World Bronchiectasis & NTM Conference organising committee member, Prof. Francesco Blasi (University of Milan and IRCCS Fondazione Cà Granda Ospedale Maggiore, Milan, Italy) to discuss the take home messages from this year’s conference, the importance of young researchers in the Bronchiectasis & NTM community and what to look forward […]